Botox breakthrough? study tests if injection depth matters for wrinkle treatment
NCT ID NCT05766683
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study compares injecting Botox at two different depths (2mm vs 4mm) to treat frown lines between the eyebrows. Twenty adults will receive a one-time treatment, and researchers will measure how well each depth reduces wrinkles and any side effects. The goal is to find the optimal injection depth for best results with minimal risks.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- onabotulinumtoxinA (Botox)
- What this could lead to
- If it works, this could help doctors choose the best injection depth for treating frown lines with Botox, possibly improving results and reducing side effects.
- What could go wrong
- This is a very small, early-phase trial with only 20 people. The results may not apply to everyone, and the difference between depths might be small or not meaningful.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for GLABELLAR FROWN LINES are added.
By submitting, you agree to our Terms of use
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Henry Ford Health System
Detroit, Michigan, 48202, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.